Abstract
Salvia miltiorrhiza Bunge, Lamiaceae, widely recognized as “danshen,” Chinese sage, is an important long-established traditional Chinese medication, and tanshinone IIA is a lipophilic component of the root extracts of this perennial plant. Modern research shows that tanshinone IIA possesses a remarkable range of pharmacological properties like antioxidant, cardio-protective, and immunomodulatory properties. It serves a protective function in different disorders ranging from cardiovascular disorders to neurodegenerative disorders. It has also been established that tanshinone IIA can block the progression of carcinoma by destroying tumor cells, encouraging cell differentiation, and triggering apoptosis. Importantly, the anti-inflammatory, anti-thrombotic, and neuroprotective functions of tanshinone IIA are due to its ability to modulate signaling pathways such as TLR/NF-κB and MAPKs/NF-κB pathway. Interestingly, nuclear factor erythroid 2–related factor 2 (Nrf2) controls the expression levels of several genes with cytoprotective effects. In addition, Nrf2 protective function has been observed in preclinical studies of liver diseases, ischemia stroke, cancer, neurodegenerative diseases, and various other brain disorders as Nrf2 activation has been found to inhibit oxidative stress and inflammation. Therefore, Nrf2 can be regarded as a possible therapeutic target for a variety of disorders. The present review aims to provide a summary of diverse in vitro and in vivo research that explored the pharmacological activities of tanshinone IIA via the Nrf-2 pathway to deliver a better understanding of its potential in different disorders.
Graphical Abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
An L, Peng LY, Sun NY, Yang YL, Zhang XW, Li B, Liu BL, Li P, Chen J (2019) Tanshinone IIA activates nuclear factor-erythroid 2-related factor 2 to restrain pulmonary fibrosis via regulation of redox homeostasis and glutaminolysis. Antioxid Redox Signal 30:1831–1848. https://doi.org/10.1089/ars.2018.7569
Ashour AA, Ramadan AA, Abdelmonsif DA, El-Kamel AH (2020) Enhanced oral bioavailability of tanshinone IIA using lipid nanocapsules: formulation, in-vitro appraisal and pharmacokinetics. Int J Pharm 586:119598. https://doi.org/10.1016/j.ijpharm.2020.119598
Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS (2007) Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med 8:50–62. https://doi.org/10.1111/j.1526-4637.2006.00179.x
Bi HC, Law FC, Zhong GP, Xu CS, Pan Y, Ding L, Chen X, Zhao LZ, Xu Q, Huang M (2007) Study of tanshinone IIA tissue distribution in rat by liquid chromatography-tandem mass spectrometry method. Biomed Chromatogr 21:473–479. https://doi.org/10.1002/bmc.778
Bi HC, Zuo Z, Chen X, Xu CS, Wen YY, Sun HY, Zhao LZ, Pan Y, Deng Y, Liu PQ et al (2008) Preclinical factors affecting the pharmacokinetic behaviour of tanshinone IIA, an investigational new drug isolated from Salvia miltiorrhiza for the treatment of ischaemic heart diseases. Xenobiotica 38:185–222. https://doi.org/10.1080/00498250701767675
Bjornsson et al., 2003 Bjornsson TD, Callaghan JT, Einolf HJ, Fischer V, Gan L, Grimm S, Kao J, King SP, Miwa G, Ni L, Kumar G, McLeod J, Obach RS, Roberts S, Roe A, Shah A, Snikeris F, Sullivan JT, Tweedie D, Vega JM, Walsh J, Wrighton SA; Pharmaceutical Research and Manufacturers of America (PhRMA) Drug Metabolism/Clinical Pharmacology Technical Working Group; FDA Center for Drug Evaluation and Research (CDER) (2003) The conduct of in vitro and in vivo drug-drug interaction studies: a pharmaceutical research and manufacturers of America (PhRMA) perspective. Drug Metab Dispos 31:815-832. https://doi.org/10.1124/dmd.31.7.815
Cai M, Guo Y, Wang S, Wei H, Sun S, Zhao G, Dong H (2017) Tanshinone IIA elicits neuroprotective effect through activating the nuclear factor erythroid 2-related factor-dependent antioxidant response. Rejuvenation Res 20:286–297. https://doi.org/10.1089/rej.2016.1912
Cai Y, Zhang W, Chen Z, Shi Z, He C, Chen M (2016) Recent insights into the biological activities and drug delivery systems of tanshinones. Int J Nanomed 11:121–130. https://doi.org/10.2147/IJN.S84035
Chen W, Yuan C, Lu Y, Zhu Q, Ma X, Xiao W, Gong W, Huang W, Xia Q, Lu G, Li W (2020) Tanshinone IIA protects against acute pancreatitis in mice by inhibiting oxidative stress via the Nrf2/ROS pathway. Oxid Med Cell Longev 2020:5390482. https://doi.org/10.1155/2020/5390482
Chen X, Wu R, Kong Y, Yang Y, Gao Y, Sun D, Liu Q, Dai D, Lu Z, Wang N, Ge S, Wang F (2017) Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation. Oncotarget 8:31915–31922. https://doi.org/10.18632/oncotarget.16651
Chen Y, Tu JH, He YJ, Zhang W, Wang G, Tan ZR, Zhou G, Fan L, Zhou HH (2009) Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers. Xenobiotica 39:508–513. https://doi.org/10.1080/00498250902951763
Chen Z, Feng H, Peng C, Zhang Z, Yuan Q, Gao H, Tang S, Xie C (2023) Renoprotective effects of tanshinone IIA: a literature review. Molecules 28:1990. https://doi.org/10.3390/molecules28041990
Cui S, Chen S, Wu Q, Chen T, Li S (2020) A network pharmacology approach to investigate the anti-inflammatory mechanism of effective ingredients from Salvia miltiorrhiza. Int Immunopharmacol 81:106040. https://doi.org/10.1016/j.intimp.2019.106040
Czyzyk A, Podfigurna A, Szeliga A, Meczekalski B (2017) Update on endometriosis pathogenesis. Minerva Ginecol 69:447–461. https://doi.org/10.23736/S0026-4784.17.04048-5
Dargan PI, Jones AL (2002) Acetaminophen poisoning: an update for the intensivist. Crit Care 6:108–110. https://doi.org/10.1186/cc1465
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, Morrison B 3rd, Stockwell BR (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072. https://doi.org/10.1016/j.cell.2012.03.042
Fang ZY, Zhang M, Liu JN, Zhao X, Zhang YQ, Fang L (2021) Tanshinone IIA: a review of its anticancer effects. Front Pharmacol 11:611087. https://doi.org/10.3389/fphar.2020.611087
Feng F, Cheng P, Xu S, Li N, Wang H, Zhang Y, Wang W (2020) Tanshinone IIA attenuates silica-induced pulmonary fibrosis via Nrf2-mediated inhibition of EMT and TGF-β1/Smadsignaling. Chem Biol Interact 319:109024. https://doi.org/10.1016/j.cbi.2020.109024
Feng F, Cheng P, Zhang H, Li N, Qi Y, Wang H, Wang Y, Wang W (2019) The protective role of tanshinone IIA in silicosis rat model via TGF-β1/Smadsignaling suppression, NOX4 inhibition and Nrf2/ARE signaling activation. Drug Des Devel Ther 13:4275–4290. https://doi.org/10.2147/DDDT.S230572
Feng FB, Qiu HY (2018) Neuroprotective effect of tanshinone IIA against neuropathic pain in diabetic rats through the Nrf2/ARE and NF-κB signaling pathways. Kaohsiung J Med Sci 34:428–437. https://doi.org/10.1016/j.kjms.2018.03.005
Fu K, Feng C, Shao L, Mei L, Cao R (2021) Tanshinone IIA exhibits anti-inflammatory and antioxidative effects in LPS-stimulated bovine endometrial epithelial cells by activating the Nrf2 signaling pathway. Res Vet Sci 136:220–226. https://doi.org/10.1016/j.rvsc.2021.03.004
Fu K, Sun Y, Wang J, Cao R (2022) Tanshinone IIa alleviates LPS-induced oxidative stress in dairy cow mammary epithelial cells by activating the Nrf2 signalling pathway. Res Vet Sci 151:149–155. https://doi.org/10.1016/j.rvsc.2022.08.008
Garabadu D, Agrawal N (2020) Naringin exhibits neuroprotection against rotenone-induced neurotoxicity in experimental rodents. Neuromolecular Med 22:314–330. https://doi.org/10.1007/s12017-019-08590-2
Garabadu D, Agrawal N, Sharma A, Sharma S (2019) Mitochondrial metabolism: a common link between neuroinflammation and neurodegeneration. Behav Pharmacol 30:642–652. https://doi.org/10.1097/FBP.0000000000000505
Ghafouri-Fard S, Shoorei H, Bahroudi Z, Hussen BM, Talebi SF, Taheri M, Ayatollahi SA (2022) Nrf2-related therapeutic effects of curcumin in different disorders. Biomolecules 12:82. https://doi.org/10.3390/biom12010082
Goyal A, Agrawal A, Verma A, Dubey N (2022) The PI3K-AKT pathway: a plausible therapeutic target in Parkinson's disease. Exp Mol Pathol 129:104846. https://doi.org/10.1016/j.yexmp.2022.104846
Guan CW, Jin J, Li J, Zhao ZX, Huang ZY (2013) Tanshinone IIA protects against triptolide-induced liver injury via Nrf2/ARE activation. Yao Xue Xue Bao 48:1397–1402
Guo R, Li L, Su J, Li S, Duncan SE, Liu Z, Fan G (2020) Pharmacological activity and mechanism of tanshinone IIA in related diseases. Drug Des Devel 14:4735–4748. https://doi.org/10.2147/DDDT.S266911
Guo Z, Yan M, Chen L, Fang P, Li Z, Wan Z, Cao S, Hou Z, Wei S, Li W, Zhang B (2018) Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity. Exp Ther Med 16:3333–3344. https://doi.org/10.3892/etm.2018.6614
Hao DC, Ge GB, Xiao PG (2018) Anticancer drug targets of Salvia phytometabolites: chemistry, biology and biology and omics. Curr Drug Targets 19:1–20. https://doi.org/10.2174/1389450117666161207141020
He F, Ru X, Wen T (2020) NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 21:4777. https://doi.org/10.3390/ijms21134777
He L, Liu YY, Wang K, Li C, Zhang W, Li ZZ, Huang XZ, Xiong Y (2021) Tanshinone IIA protects human coronary artery endothelial cells from ferroptosis by activating the NRF2 pathway. Biochem Biophys Res Commun 575:1–7. https://doi.org/10.1016/j.bbrc.2021.08.067
Huang P, Wan H, Shao C, Li C, Zhang L, He Y (2022) Recent advances in Chinese herbal medicine for cerebral ischemic reperfusion injury. Front Pharmacol 12:688596. https://doi.org/10.3389/fphar.2021.688596
Huichang B, Fan H, Yingying W, Xiao C, Min H (2007) Metabolic kinetics of tanshinone IIA in rat liver microsomal enzyme. Chin Tradit Herb Drugs 38:882–886
James MT, Samuel SM, Manning MA, Tonelli M, Ghali WA, Faris P, Knudtson ML, Pannu N, Hemmelgarn BR (2013) Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv 6:37–43. https://doi.org/10.1161/CIRCINTERVENTIONS.112.974493
Ji XY, Tan BK, Zhu YZ (2000) Salvia miltiorrhiza and ischemic diseases. Acta Pharmacol Sin 21:1089–1094
Jia Y, Huang F, Zhang S, Leung SW (2012) Is danshen (Salvia miltiorrhiza) dripping pill more effective than isosorbidedinitrate in treating angina pectoris? A systematic review of randomized controlled trials. Int J Cardiol 157:330–340. https://doi.org/10.1016/j.ijcard.2010.12.073
Jiang Z, Gao W, Huang L (2019) Tanshinones, critical pharmacological components in Salvia miltiorrhiza. Front Pharmacol 10:202. https://doi.org/10.3389/fphar.2019.00202
Larson et al, 2005 Larson AM, Polson J, Fontana RJ, Davern TJ, Lalani E, Hynan LS, Reisch JS, Schiødt FV, Ostapowicz G, Shakil AO, Lee WM, Acute Liver Failure Study Group (2005) Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology 42:1364-1372. https://doi.org/10.1002/hep.20948
Leung CC, Yu IT, Chen W (2012) Silicosis. Lancet 379:2008-2018. https://doi.org/10.1016/S0140-6736(12)60235-9
Li JF, Wei YX, Xu ZC, Dong C, Shuang SM (2004) Studies on the spectroscopic behavior of cryptotanshinone, tanshinone IIA, and tanshinone I. Spectrochim Acta A Mol Biomol Spectrosc 60:751–756. https://doi.org/10.1016/S1386-1425(03)00286-5
Li MH, Chen JM, Peng Y, Wu Q, Xiao PG (2008) Investigation of danshen and related medicinal plants in China. J Ethnopharmacol 120:419–426. https://doi.org/10.1016/j.jep.2008.09.013
Li Z, Zou J, Cao D, Ma X (2020) Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases. Biomed Pharmacother 130:110599. https://doi.org/10.1016/j.biopha.2020.110599
Liang R, Zhao Q, Jian G, Cheng D, Wang N, Zhang G, Wang F (2018) Tanshinone IIA attenuates contrast-induced nephropathy via Nrf2 activation in rats. Cell Physiol Biochem 46:2616–2623. https://doi.org/10.1159/000489688
Liu D, Dong Z, Xiang F, Liu H, Wang Y, Wang Q, Rao J (2020) Dendrobium alkaloids promote neural function after cerebral ischemia-reperfusion injury through inhibiting pyroptosis induced neuronal death in both in vivo and in vitro models. Neurochem Res 45:437–454. https://doi.org/10.1007/s11064-019-02935-w
Liu HX, Hu Y, Liu Y, He YQ, Li W, Yang L (2009) Hydroxylation of tanshinone IIa in human liver microsomes is specifically catalysed by cytochrome P4502A6. Xenobiotica 39:382–390. https://doi.org/10.1080/00498250902818335
Lu TC, Wu YH, Chen WY, Hung YC (2022) Targeting oxidative stress and endothelial dysfunction using tanshinone IIA for the treatment of tissue inflammation and fibrosis. Oxid Med Cell Longev 2022:2811789. https://doi.org/10.1155/2022/2811789
Lu Z, Cheng D, Yin J, Wu R, Zhang G, Zhao Q, Wang N, Wang F, Liang M (2017) Antithrombin III protects against contrast-induced nephropathy. EBioMedicine 17:101–107. https://doi.org/10.1016/j.ebiom.2017.02.009
Luo J, Song W, Yang G, Xu H, Chen K (2015) Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews. Am J Chin Med 43:25–43. https://doi.org/10.1142/S0192415X15500020
Ma L, Tang L, Yi Q (2019) Salvianolic acids: potential source of natural drugs for the treatment of fibrosis disease and cancer. Front Pharmacol 10:97. https://doi.org/10.3389/fphar.2019.00097
Manwani B, McCullough LD (2013) Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke. J Neurosci Res 91:1018–1029. https://doi.org/10.1002/jnr.23207
Mao S, Wang L, Zhao X, Guo L, Lin Q, Wang X, Dai X, Shang H, Zhang M, Hinek A (2021) Efficacy of sodium tanshinone IIA sulfonate in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results from a multicentre, controlled, randomized trial. Cardiovasc Drugs Ther 35:321–329. https://doi.org/10.1007/s10557-020-07077-8
Mehedintu C, Plotogea MN, Ionescu S, Antonovici M (2014) Endometriosis still a challenge. J Med Life 7:349–357
Miao Q, Wang R, Sun X, Du S, Liu L (2022) Combination of puerarin and tanshinone IIA alleviates ischaemic stroke injury in rats via activating the Nrf2/ARE signalling pathway. Pharm Biol 60:1022–1031. https://doi.org/10.1080/13880209.2022.2070221
Ritter J, Bielack SS (2010) Osteosarcoma. Ann Oncol 21:VII320-VII325. https://doi.org/10.1093/annonc/mdq276
Sheldon IM, Cronin JG, Bromfield JJ (2019) Tolerance and innate immunity shape the development of postpartum uterine disease and the impact of endometritis in dairy cattle. Annu Rev Anim Biosci 7:361–384. https://doi.org/10.1146/annurev-animal-020518-115227
Subedi L, Gaire BP (2021) Tanshinone IIA: A phytochemical as a promising drug candidate for neurodegenerative diseases. Pharmacol Res 169:105661. https://doi.org/10.1016/j.phrs.2021.105661
Tebay LE, Robertson H, Durant ST, Vitale SR, Penning TM, Dinkova-KostovaAT HJD (2022) Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease. Free Radic Biol Med 88:108–146. https://doi.org/10.1016/j.freeradbiomed.2015.06.021
Tian HL, Yu T, Xu NN, Feng C, Zhou LY, Luo HW, Chang DC, Le XF, Luo KQ (2010) A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway. Cancer Lett 297:18–30. https://doi.org/10.1016/j.canlet.2010.04.020
Tsai YT, Loh SH, Lee CY, Lee SP, Chen YL, Cheng TH, Tsai CS (2018) Tanshinone IIA inhibits high glucose-induced collagen synthesis via nuclear factor erythroid 2-related factor 2 in cardiac fibroblasts. Cell Physiol Biochem 51:2250–2261. https://doi.org/10.1159/000495870
Varshney KK, Gupta JK, Mujwar S (2019) Homocysteine induced neurological dysfunctions: a link to neurodegenerative disorders. Int J Med Res Health Sci 8:135–146
Wang F, Li J, Huang B, Zhao Q, Yu G, Xuan C, Wei M, Wang N (2013) Clinical survey on contrast-induced nephropathy after coronary angiography. Ren Fail 35:1255–1259. https://doi.org/10.3109/0886022X.2013.823874
Wang L, Zhang C, Guo Y, Su ZY, Yang Y, Shu L, Kong AN (2014) Blocking of JB6 cell transformation by tanshinone IIA: Epigenetic reactivation of Nrf2 antioxidative stress pathway. AAPS J 16:1214–1225. https://doi.org/10.1208/s12248-014-9666-8
Wang T, Wang C, Wu Q, Zheng K, Chen J, Lan Y, Qin Y, Mei W, Wang B (2017) Evaluation of tanshinone IIA developmental toxicity in zebrafish embryos. Molecules 22:660. https://doi.org/10.3390/molecules22040660
Wang W, Guan C, Sun X, Zhao Z, Li J, Fu X, Qiu Y, Huang M, Jin J, Huang Z (2016) Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway. Phytomedicine 23:589–596. https://doi.org/10.1016/j.phymed.2016.02.022
Wang X, Morris-Natschke SL, Lee KH (2007) New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 27:133–148. https://doi.org/10.1002/med.20077
Wei Y, Li P, Wang C, Peng Y, Shu L, Jia X, Ma W, Wang B (2012) Metabolism of tanshinone IIA, cryptotanshinone and tanshinone I from Radix Salvia miltiorrhiza in zebrafish. Molecules 17:8617–8632. https://doi.org/10.3390/molecules17078617
Xi C, Peng S, Wu Z, Zhou Q, Zhou J (2017) Toxicity of triptolide and the molecular mechanisms involved. Biomed Pharmacother 90:531–541. https://doi.org/10.1016/j.biopha.2017.04.003
Xie Z, He B, Jiang Z, Zhao L (2020) Tanshinone IIA inhibits osteosarcoma growth through modulation of AMPK-Nrf2 signaling pathway. J Recept Signal Transduct Res 40:591–598. https://doi.org/10.1080/10799893.2020.1772296
Xu S, Liu P (2013) Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat 23:149–153. https://doi.org/10.1517/13543776.2013.743995
Yadav S, Singh M, Singh SN, Kumar B (2020) Tanshinone IIA pretreatment promotes cell survival in human lung epithelial cells under hypoxia via AP-1-Nrf2 transcription factor. Cell Stress Chaperones 25:427–440. https://doi.org/10.1007/s12192-020-01083-3
Yang G, Wang F, Wang Y, Yu X, Yang S, Xu H, Xing J (2020a) Protective effect of tanshinone IIA on H2O2-induced oxidative stress injury in rat cardiomyocytes by activating Nrf2 pathway. J Recept Signal Transduct Res 40:264–272. https://doi.org/10.1080/10799893.2020.1731535
Yang LJ, Jeng CJ, Kung HN, Chang CC, Wang AG, Chau GY, Don MJ, Chau YP (2005) Tanshinone IIA isolated from Salvia miltiorrhiza elicits the cell death of human endothelial cells. J Biomed Sci 12:347–361. https://doi.org/10.1007/s11373-005-0973-z
Yang Y, Liu L, Zhang X, Jiang X, Wang L (2020b) Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2. Liver Int 40:141–154. https://doi.org/10.1111/liv.14262
Yue S, Hu B, Wang Z, Yue Z, Wang F, Zhao Y, Yang Z, Shen M (2014) Salvia miltiorrhiza compounds protect the liver from acute injury by regulation of p38 and NFκB signaling in Kupffer cells. Pharm Biol 52:1278–1285. https://doi.org/10.3109/13880209.2014.889720
Zhang HS, Chen XY, Wu TC, Zhang FJ (2014) Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway. J Cell Physiol 229:1193–1201. https://doi.org/10.1002/jcp.24552
Zhang HS, Wang SQ (2007) Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells. Biochem Pharmacol 73:1358–1366. https://doi.org/10.1016/j.bcp.2007.01.004
Zhang J, Wang Y, Ji X, Shu Z (2019a) Tanshinone IIA protects against dopaminergic neuron degeneration via regulation of DJ-1 and Nrf2/HO-1 pathways in a rodent model of Parkinson’s disease. Trop J Pharm Res 18:1017–1025
Zhang WX, Xiao XY, Peng CG, Chen WL, Xie S, Wang DW (2019b) Sodium tanshinone IIA sulfate protects myocardium against paraquat-induced toxicity through activating the Nrf2 signaling pathway in rats. Hum Exp Toxicol 38:247–254. https://doi.org/10.1177/0960327118792051
Zhang X, Long F, Li R, Yang Y, Wang T, He Q, Xu M, Wang L, Jiang X (2022) Tanshinone IIA prevents acetaminophen-induced nephrotoxicity through the activation of the Nrf2-Mrp2/4 pathway in mice. Environ Toxicol 37:1618–1628. https://doi.org/10.1002/tox.23511
Zhang X, Wang T, Yang Y, Li R, Chen Y, Li R, Jiang X, Wang L (2020) Tanshinone IIA attenuates acetaminophen-induced hepatotoxicity through HOTAIR-Nrf2-MRP2/4 signaling pathway. Biomed Pharmacother 130:110547. https://doi.org/10.1016/j.biopha.2020.110547
Zhang XS, Ha S, Wang XL, Shi YL, Duan SS, Li ZA (2015) Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway. Neuroscience 303:489–502. https://doi.org/10.1016/j.neuroscience.2015.06.030
Zhang Y, Jiang P, Ye M, Kim SH, Jiang C, Lü J (2012) Tanshinones: sources, pharmacokinetics and anti-cancer activities. Int J Mol Sci 13:13621–13666. https://doi.org/10.3390/ijms131013621
Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345–1359. https://doi.org/10.1177/0091270005282630
Zhu X, He L, Gao W, Zhao Z (2023) Neuroprotective investigation of tanshinone in the cerebral infarction model in the Keap1-Nrf2/ARE pathway. Cell Cycle 22:390–402. https://doi.org/10.1080/15384101.2022.2119687
Zhu Z, Li Q, Xu C, Zhao J, Li S, Wang Y, Tian L (2020) Sodium tanshinone IIA sulfonate attenuates silica-induced pulmonary fibrosis in rats via activation of the Nrf2 and thioredoxin system. Environ Toxicol Pharmacol 80:103461. https://doi.org/10.1016/j.etap.2020.103461
Zhu Z, Wang Y, Liang D, Yang G, Chen L, Niu P, Tian L (2015) Sodium tanshinone IIA sulfonate suppresses pulmonary fibroblast proliferation and activation induced by silica: Role of the Nrf2/Trx pathway. Toxicol Res 5:116–125. https://doi.org/10.1039/c5tx00291e
Zhuang S, Cheng TH, Shih NL, Liu JC, Chen JJ, Hong HJ, Chan P (2016) Tanshinone IIA induces heme oxygenase 1 expression and inhibits cyclic strain-induced interleukin 8 expression in vascular endothelial cells. Am J Chin Med 44:377–388. https://doi.org/10.1142/S0192415X1650021X
Acknowledgements
We are thankful to BioRender for providing the platform to create professional science figures.
Author information
Authors and Affiliations
Contributions
AG and AV designed the layout of the manuscript. PV and K collected the relevant data from different search engines. All authors contributed equally to the writing of the manuscript. They have read and approved the final submission.
Corresponding author
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Verma, A., Kumari, K., Varshney, P. et al. Pharmacological Actions of Tanshinone IIA with Special Focus on Nrf-2 Signaling Pathway. Rev. Bras. Farmacogn. 33, 924–935 (2023). https://doi.org/10.1007/s43450-023-00421-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43450-023-00421-7